Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOSERGEN-AB-124120278/news/Biosergen-Conducts-A-New-Phase-1B-Study-in-Patients-with-Invasive-Fungal-Infections-with-Its-Drug-Ca-45730069/?utm_source=whatsapp&utm_medium=social&utm_campaign=share